“…By combining diagnostic and therapeutic capabilities, nanotheranostic systems make it possible to detect and treat cardiac toxicity all at once. Common components of such platforms include nanoparticles designed to transport diagnostic imaging agents and therapeutic intervention agents 12 . When it comes to cardiotoxicity, there are nanotheranostic platforms that can be developed to identify changes in the cardiac system.…”